Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga
- 期刊名称Current Pharmacogenomics and Personalized Medicine
- 作者So, Derek; Joly, Yann
- 卷第11卷
- 期第2期
- 印刷ISSN1875-6921
- 文件大小221.73KB
- 发表时间2013-05-01
- DOI10.2174/1875692111311020003
- 页码98-109
Malignancy-Associated DyslipidemiaBielecka-Dąbrowa, Agata · The Open Cardiovascular Medicine Journal · 2011
HIV and HAART-Associated DyslipidemiaFeeney, Eoin R. · The Open Cardiovascular Medicine Journal · 2011
Health Measurement Scales: Methodological IssuesPanagiotakos, Demosthenes · The Open Cardiovascular Medicine Journal · 2009
Dyslipidemia Associated with Chronic Kidney DiseaseTsimihodimos, Vasilis · The Open Cardiovascular Medicine Journal · 2011
Effects of Thyroid Dysfunction on Lipid ProfileRizos, C.V. · The Open Cardiovascular Medicine Journal · 2011
Pharmacokinetic Considerations for Digoxin in Older PeopleCurrie, Geoffrey M. · The Open Cardiovascular Medicine Journal · 2011
Post-traumatic Stress Disorder and Cardiovascular DiseaseCoughlin, Steven S. · The Open Cardiovascular Medicine Journal · 2011
The Value of p-Value in Biomedical ResearchPanagiotakos, Demosthenes B. · The Open Cardiovascular Medicine Journal · 2008